EVALUATION OF BIOAVAILABILITY DATA

被引:0
|
作者
MCGILVERAY, IJ [1 ]
HUGHES, DW [1 ]
机构
[1] BUR DRUG RES,BIOPHARMACEUT SECT,OTTAWA K1A 0L2,ONTARIO,CANADA
来源
PHARMACOPEIAL FORUM | 1990年 / 16卷 / 02期
关键词
D O I
暂无
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
引用
收藏
页码:322 / 322
页数:1
相关论文
共 50 条
  • [21] HYDROCHLOROTHIAZIDE BIOAVAILABILITY - EVALUATION OF 13 PRODUCTS
    MEYER, MC
    MELIKIAN, AP
    WHYATT, PL
    SLYWKA, GWA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1975, 17 (06): : 570 - 577
  • [22] PROPOXYPHENE BIOAVAILABILITY - EVALUATION OF 10 PRODUCTS
    SLYWKA, GWA
    MELIKIAN, AP
    WHYATT, PL
    MEYER, MC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (8-9): : 598 - 604
  • [23] EVALUATION OF BIOAVAILABILITY OF DIGOXIN TABLETS AND CAPSULES
    ICASASCABRAL, E
    CAPA, H
    ZARATE, MV
    DAYRIT, C
    PHILIPPINE JOURNAL OF INTERNAL MEDICINE, 1979, 17 (04): : 185 - 194
  • [25] USE OF BIOAVAILABILITY DATA BY PRACTITIONERS .2. PRELIMINARY-REPORT OF EVALUATION SKILLS OF PHARMACISTS AND PHYSICIANS
    VINSON, BE
    SCHUMACHER, GE
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1976, 33 (11): : 1164 - 1166
  • [26] DETECTION OF OUTLYING DATA IN BIOAVAILABILITY BIOEQUIVALENCE STUDIES
    LIU, JP
    WENG, CS
    STATISTICS IN MEDICINE, 1991, 10 (09) : 1375 - 1389
  • [27] LIMITATIONS IN USE OF METABOLITE DATA IN BIOAVAILABILITY ASSESSMENT
    ANSLOW, JA
    CHAN, MY
    GREENE, IS
    HOOPER, JW
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 253 - 253
  • [28] ABSOLUTE BIOAVAILABILITY ESTIMATED FROM ORAL DATA
    HINDERLING, PH
    SHI, JM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (03) : 385 - 386
  • [29] USE OF PHARMACOLOGICAL DATA FOR BIOAVAILABILITY AND PHARMACOKINETIC ANALYSES
    KRAMER, PA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (04) : 580 - 583
  • [30] Bioavailability enhancement with humic substances and their comparative evaluation
    Mirza, M. A.
    Agarwal, S. P.
    Khar, R. K.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A60 - A60